News
Your search is "" and there are 2637 results
【Insights】TROP2:Datroway approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer
2025-06-25
【Insights】What’s Next After GLP-1? ActRII Ignites a New Wave of High-Quality Weight Loss
2025-07-01
【Insights】IL-11:AbbVie to Acquire Capstan Therapeutics,Further Strengthening Commitment to Transforming Patient Care in Immunology
2025-07-03
【Insights】PD-1/VEGF: Summit, AstraZeneca in talks over $15 billion cancer drug licensing deal, Bloomberg News reports
2025-07-10
【Insights】CD276 Heats Up: The Race for the Next Blockbuster ADC
2025-07-17
【Insights】CLDN18.2×4-1BB:I-Mab Strengthens Givastomig Intellectual Property Portfolio through Acquisition of Bridge Health
2025-07-18
【Insights】OX40/OX40L: Broadly Involved in Inflammation, Autoimmunity, and Cancer
2025-07-24
【Insights】IL-23 in the Spotlight: Tremfya® Advances in Crohn’s Disease
2025-07-25
【Insights】GLP1R:Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited
2025-07-31
【Insights】Securing Market Share in the IL-17 Era: First Movers vs Fast Followers
2025-08-01
【Insights】GLP-1R/GCGR/GIPR:Novo Nordisk Delivers Strong H1 2025 Results, Driven by Soaring GLP-1 Drug Sales
2025-08-07
【Insights】DLL3 Target Trend Surges: A Rising Star in Small Cell Lung Cancer Therapy
2025-09-03
【Insights】Rise of PD-1/VEGF/CTLA-4 Triple Antibodies: Immunotherapy 2.0 and Its Accelerated Development
2025-09-05
【Insights】TSLP: The Emerging Key Target in Autoimmune Diseases
2025-09-05
【Insights】OX40L:Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study
2025-09-05
【Insights】The Multifaceted Role of Claudin-1: Regulation of Cancer, Inflammation, and Fibrosis with Therapeutic Implications
2025-09-10
【Insights】2025 WCLC Witnesses: EGFR-Mutant NSCLC Enters the EGFR×HER3 Dual-Target Combination Era
2025-09-17
【News】会议邀请 | 诚邀您莅临第二十届CACLP 吉满展位号A7-2223
2024-01-08
【News】会议邀请 | 诚邀您莅临第二十届CACLP 吉满展位号A7-2223
2024-01-08
【Customer Literature】IF=13.933,Metabolism-Clinical and Experimental,山东大学附属山东省立医院,干扰慢病毒
2014-02-14
First 19 20 21 22 23 Last
Total 132 Page
Jump
More
Message consultation
reset
submit
Service
Message
Message consultation
reset
submit